Disease Information

Leukemias / Lymphomas: Myelodysplasia (MDS)

Alternate Names: MDS

What is myelodysplasia?

Myelodysplasia (MDS) refers to a group of disorders related to the body’s inability to produce enough normal blood cells. Bone marrow, the spongy material inside bones, makes these cells.

MDS can reduce production of any, and sometimes all, blood cells:

As a result, patients with MDS are more likely to develop the following:

In about 30 percent of patients, MDS progresses to a disease called acute myeloid leukemia. Learn more about acute myeloid leukemia.

How common is myelodysplasia?

What are the symptoms of myelodysplasia?

Up to 20% of children with certain types of MDS will have no symptoms. Some of the more noticeable symptoms of MDS in children include:

How is myelodysplasia treated?

The most effective treatment for most types of MDS is called allogeneic stem cell/bone marrow transplantation. Learn more about this treatment at: Allogeneic Stem Cell/Bone Marrow Transplant.

Other therapies that may be used to treat MDS include:

What are the survival rates for myelodysplasia?

MDS has a long-term survival rate of up to 60% in patients treated with allogeneic stem cell/bone marrow transplantation.

Why choose St. Jude for your child’s myelodysplasia treatment?


The St. Jude Web site is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through this site should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, you should consult your health care provider.